There have been growing claims that regular use of aspirin could in fact help in the treatment of cancers and also lower the risk of the disease spreading.
Researchers from the Cardiff University went on to review 71 medical studies, looking at the survival rate of more than 120.000 cancer patients who took acetylsalicylic acid (ASA), compared to data from 400.000 cases where patients had not.
Their findings were quite surprising – a survival rate of people that had taken the pill after diagnosis and throughout the cancer treatment was about 20 to 30 percent higher than those who did not, hinting that there might actually be a connection.
“The use of low-dose Aspirin as a preventive in heart disease, stroke, and cancer is well established but the evidence is now emerging that the drug may have a valuable role as an additional treatment for cancer too”, said Peter Elwood, Honorary Professor at Cardiff University.
One paper exploring colon cancer suggested that a non-diabetic man of about 65 years who takes aspirin could have the same prognosis as someone five years younger who does not. For a woman in a similar case, the use of ASA could mean a prognosis as for someone four years younger.
Overall, many of the articles studied were regarding bowel cancer, but there was also a good percentage of breast and prostate cancer research. Other less common forms of malignancy were not well represented, though results seem to indicate that aspirin does provide some benefits.
Clinical trials have been set up to corroborate the observational data gathered. In the meantime, the findings should be taken with a grain of salt